International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5281/zenodo.14560518
Original Research Article
Assessing Post Endodontic Pain with two different file system using dynamic irrigation technique: A randomised clinical trial
Published
Dec. 27, 2024
Abstract

Introduction: Immediate condition just after root canal therapy takes a first impression of treatment as well as clinician’s ability. In this pretext, evaluation of reduction of PEP using two different file system with Endoactivator is done. Aim: Evaluation of post endodontic pain after using Endoactivator with ProTaper Gold and ProTaper Next file system in single visit root canal treatment. Material method: A total of 100 patients were assigned who required endodontic treatment. They were divided into two groups: Group 1 (PTG-EA) and Group 2 (PTNEA). Single visit root canal was performed under local anesthesia. Endoactivator was used for final irrigation protocol in all groups. The intensity of post endodontic pain (PEP) was evaluated by Visual Analogue Scale VAS score after 6,12,24 and 48 hours. Final data was combined and statically analyzed with the help of SPSS 20.0 software at a level of being significance being 0.05. Results: As compared to ProTaper Gold, ProTaper Next showed the least score at 6 and 12 hours of PEP, there was a statistically significant difference noted. At 24 and 48 hours no statistically significance difference was noted among two groups. Conclusion: The intensity of PEP was minimum when treated with ProTaper Next file system along with Endoactivator.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1676 Views
419 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved